The exposure of peripheral blood mononuclear cells isolated from RA patients to this compound led to a consistent upregulation of FoxP3, TGF-β, and IL-10 in CD4+ cells, an enhancement of Treg cell suppressive activity [85], and a reduction of IL-17 mRNA [86]. The gene discussed is CD4; the disease is rheumatoid arthritis.